中枢神经系统肿瘤

CAR-T 细胞治疗：儿童脑肿瘤的治疗潜力——最新进展

CAR-T cell therapy: potential for paediatric brain tumours-an update.

现有与新兴 CAR-T 细胞疗法的神经系统并发症

Neurological complications of current and emerging CAR-T cell therapies.

CAR-T 细胞用于儿童 CNS 肿瘤：临床经验与反向转化机会

CAR T cells for pediatric CNS tumors: Clinical experience and reverse translational opportunities.

免疫效应细胞相关神经毒性综合征：CAR-T 细胞治疗中整合机制、预测性生物标志物及预防的转化路径

Immune effector cell-associated neurotoxicity syndrome: integrative mechanisms, predictive biomarkers, and translational pathways for prevention in CA

B7-H3 靶向 NK 细胞有效杀伤非典型畸胎样/横纹肌样肿瘤并延长原位异种移植模型生存期

B7-H3-targeted natural killer cells effectively kill atypical teratoid / rhabdoid tumors and extend survival in orthotopic xenografts.

抗 B7-H3 CAR-NK 细胞在多种临床前体外和体内模型中，以抗原特异性方式有效杀伤 AT/RT。

中枢神经系统肿瘤的免疫治疗及其神经系统并发症

Immunotherapies for Central Nervous System Tumors and their Neurologic Complications.

CAR-T 细胞疗法治疗中枢神经系统肿瘤

CAR-T Cell Therapy for Central Nervous System Tumors.

针对中枢神经系统恶性肿瘤患者的 CAR-T 细胞开发

The development of CAR T cells for patients with CNS malignancies.

间皮素是人类脑膜瘤上存在的一种表面抗原，可被 CAR-T 细胞有效靶向

Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells.

间皮素是脑膜瘤的一个可行 CAR-T 细胞靶点，间皮素特异性 CAR-T 细胞疗法显示出强大的临床前疗效。这些发现为间皮素 CAR-T 细胞疗法在难治性脑膜瘤患者中的早期临床试验提供了依据。

中枢神经系统肿瘤中的 CAR-T：有前景的科学与缓慢的临床进展

CAR-T in Central Nervous System Tumours: Promising Science, Slow Clinical Progress.